Dieter Magometschnigg

Summary

Affiliation: University of Vienna Medical School
Country: Austria

Publications

  1. ncbi [Blood pressure and arterial stiffness. A comparison of two devices for measuring augmentationindex and pulse wave velocity]
    Dieter Magometschnigg
    Institut für Hypertoniker, Wien, Osterreich
    Wien Med Wochenschr 155:404-10. 2005
  2. ncbi [The theory-practice problem of blood pressure assessment]
    Dieter Magometschnigg
    Institut für Hypertoniker, Wien, Osterreich
    Wien Med Wochenschr 154:20-3. 2004
  3. ncbi [Hypertension: why are therapeutic standards so poorly implemented in the clinical practice]
    Dieter Magometschnigg
    , Kinderspitalgasse, Wien
    Wien Klin Wochenschr 117:508-9. 2005
  4. ncbi [Clinical pharmacology of angiotensin II receptor antagonists]
    G Hitzenberger
    Gesellschaft für klinische Pharmakologie, Kinderspitalgasse 10 16, A 1090 Wien
    Wien Med Wochenschr 151:151-2. 2001
  5. ncbi [Ethical problems in the clinical evaluation of drugs--role of ethics committees]
    G Hitzenberger
    Institut für Hypertoniker, Kinderspitalgasse 10, A 1090 Wien
    Wien Med Wochenschr 152:320-2. 2002
  6. ncbi [The effect of a homeopathic drug on the blood pressure of hypertensive patients--a randomised double-blind controlled parallel group comparative trial]
    Gerhart Hitzenberger
    Institut für Hypertoniker, Wien, Osterreich
    Wien Med Wochenschr 155:392-6. 2005
  7. ncbi Blood pressure characteristics of hypertensive patients in Austria as determined by self-monitoring (SCREEN-II)
    G Hitzenberger
    Institut für Hypertoniker, Wien, Austria
    Blood Press 12:134-8. 2003
  8. ncbi [Hypertension 2004]
    Gerhart Hitzenberger
    Institut für Hypertoniker, Wien, Osterreich
    Wien Med Wochenschr 154:2-7. 2004
  9. ncbi [How reproducible is blood pressure measurement? Intra- and interindividual blood pressure variability in routine practice]
    D Magometschnigg
    Institut für Hypertoniker, Wien
    Wien Med Wochenschr 149:608-15. 1999
  10. ncbi [Hypertension--the status in Austria]
    G Hitzenberger
    Institut für Hypertoniker, Wien
    Wien Med Wochenschr 149:616-20. 1999

Detail Information

Publications15

  1. ncbi [Blood pressure and arterial stiffness. A comparison of two devices for measuring augmentationindex and pulse wave velocity]
    Dieter Magometschnigg
    Institut für Hypertoniker, Wien, Osterreich
    Wien Med Wochenschr 155:404-10. 2005
    ..4 +/- SD: 1.5 m/sec. As in AIx, these results were also different, but in contrast to AIx they did not correlate (r = -0.04) because PWV depend on the artery and its physical characteristics, and we..
  2. ncbi [The theory-practice problem of blood pressure assessment]
    Dieter Magometschnigg
    Institut für Hypertoniker, Wien, Osterreich
    Wien Med Wochenschr 154:20-3. 2004
    ..The problem can be avoided if, instead of single values, mean values out of a sufficient number of measurements and their confidence intervals are assessed...
  3. ncbi [Hypertension: why are therapeutic standards so poorly implemented in the clinical practice]
    Dieter Magometschnigg
    , Kinderspitalgasse, Wien
    Wien Klin Wochenschr 117:508-9. 2005
  4. ncbi [Clinical pharmacology of angiotensin II receptor antagonists]
    G Hitzenberger
    Gesellschaft für klinische Pharmakologie, Kinderspitalgasse 10 16, A 1090 Wien
    Wien Med Wochenschr 151:151-2. 2001
    ..This receptor contains 2 subtypes, which are influenced by these antagonists in a different way. The marketed drugs of this group have different pharmacokinetic properties...
  5. ncbi [Ethical problems in the clinical evaluation of drugs--role of ethics committees]
    G Hitzenberger
    Institut für Hypertoniker, Kinderspitalgasse 10, A 1090 Wien
    Wien Med Wochenschr 152:320-2. 2002
    ....
  6. ncbi [The effect of a homeopathic drug on the blood pressure of hypertensive patients--a randomised double-blind controlled parallel group comparative trial]
    Gerhart Hitzenberger
    Institut für Hypertoniker, Wien, Osterreich
    Wien Med Wochenschr 155:392-6. 2005
    ..Blood lipids (cholesterol, HDL-, LDL-cholesterol and triglyzerides) did not change, neither in the placebo nor in the verum group...
  7. ncbi Blood pressure characteristics of hypertensive patients in Austria as determined by self-monitoring (SCREEN-II)
    G Hitzenberger
    Institut für Hypertoniker, Wien, Austria
    Blood Press 12:134-8. 2003
    ....
  8. ncbi [Hypertension 2004]
    Gerhart Hitzenberger
    Institut für Hypertoniker, Wien, Osterreich
    Wien Med Wochenschr 154:2-7. 2004
    ..Treatment for hypertension both concerning advice on the necessary change in lifestyle and medication is on the whole unsatisfactory. Suggestions for optimizing the respective strategies are given...
  9. ncbi [How reproducible is blood pressure measurement? Intra- and interindividual blood pressure variability in routine practice]
    D Magometschnigg
    Institut für Hypertoniker, Wien
    Wien Med Wochenschr 149:608-15. 1999
    ..If this is true, daily self-recordings should be the most promising approach...
  10. ncbi [Hypertension--the status in Austria]
    G Hitzenberger
    Institut für Hypertoniker, Wien
    Wien Med Wochenschr 149:616-20. 1999
    ..Among physicians these values are even worse: nearly two thirds show an elevated pressure, but only 20% of them are treated. Treatment itself is unsatisfactory: nearly 100% of patients receive a monotherapy only...
  11. ncbi [Hypertension short message service]
    Dieter Magometschnigg
    Institut für Hypertoniker, Kinderspitalgasse 10 15 16, Vienna, Austria
    Wien Med Wochenschr 161:353-8. 2011
    ..As we are aware of the weakness of registry analysis we try to set up a controlled prospective study to compare "Blutdrucksms" users to non-users...
  12. ncbi [Education for medical career]
    R N Braun
    Arbeitsgemeinschaft zur Erforschung der Allgemeinmedizin, , Wien
    Wien Med Wochenschr 152:476-8. 2002
    ..It should be found out how to guarantee that the profession is pursued till to it's end on the highest possible level. Results of research concerning the latter topic don't exist at present...
  13. ncbi Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reduction
    Bjorn Dahlof
    Clinical Experimental Research Laboratory, Department of Medicine, Sahlgrenska University Hospital Ostra, Goteborg, Sweden
    Am J Hypertens 18:1313-9. 2005
    ..The primary objective of this study was to compare the effects on HRQL of initiating treatment with felodipine + metoprolol (F+M) fixed combination tablets, or enalapril (E), or placebo (P)...
  14. ncbi Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study
    Bjorn Dahlof
    Goteborg University, Sweden
    J Hypertens 23:2063-70. 2005
    ..The PICXEL study compared the efficacy of a strategy based on first-line combination with perindopril/indapamide versus monotherapy with enalapril in reducing left ventricular hypertrophy (LVH) in hypertensive patients...
  15. ncbi The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy
    Stevo Julius
    University of Michigan, Department of Internal Medicine, Division of Cardiovascular Medicine, 24 Frank Lloyd Wright Dr, PO Box 322, Lobby M, Ann Arbor, MI 48106, USA
    Hypertension 48:385-91. 2006
    ..Moreover, these findings support the feasibility of comparative prospective trials in lower-risk hypertensive patients...